Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59. (Q40543421)

21 September 2017

Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59. (English)

1 reference

21 September 2017

2

Kathryn V Holmes

1 reference

21 September 2017

1

Larissa B Thackray

1 reference

PubMed ID

15207636

21 September 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

21 September 2017

1 reference

21 September 2017

324

1 reference

21 September 2017

2

1 reference

21 September 2017

510-524

1 reference

Redefined nomenclature for members of the carcinoembryonic antigen family.

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Virus detectives seek source of SARS in China's wild animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Monoclonal antibodies to bovine coronavirus glycoproteins E2 and E3: demonstration of in vivo virus-neutralizing activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Coronavirus spike proteins in viral entry and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Switching species tropism: an effective way to manipulate the feline coronavirus genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Virus-receptor interactions and interspecies transfer of a mouse hepatitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

SARS coronavirus: a new challenge for prevention and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

A novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Viral zoonoses - a threat under control?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

The Genome sequence of the SARS-associated coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Receptor-induced conformational changes of murine coronavirus spike protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Coronavirus as a possible cause of severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

The spike but not the hemagglutinin/esterase protein of bovine coronavirus is necessary and sufficient for viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

The N-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Bovine coronavirus uses N-acetyl-9-O-acetylneuraminic acid as a receptor determinant to initiate the infection of cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Monoclonal Antibody to the Receptor for Murine Coronavirus MHV-A59 Inhibits Viral Replication In Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Evidence from the evolutionary analysis of nucleotide sequences for a recombinant history of SARS-CoV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Mosaic evolution of the severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Population biology of emerging and re-emerging pathogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Human aminopeptidase N is a receptor for human coronavirus 229E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

Persistent infection promotes cross-species transmissibility of mouse hepatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

Interaction of mouse hepatitis virus (MHV) spike glycoprotein with receptor glycoprotein MHVR is required for infection with an MHV strain that expresses the hemagglutinin-esterase glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

Persistent infection of cultured cells with mouse hepatitis virus (MHV) results from the epigenetic expression of the MHV receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

Mutational analysis of the virus and monoclonal antibody binding sites in MHVR, the cellular receptor of the murine coronavirus mouse hepatitis virus strain A59

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

Coronavirus species specificity: murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein

1 reference

12 December 2020

Expression of the recombinant anchorless N-terminal domain of mouse hepatitis virus (MHV) receptor makes hamster of human cells susceptible to MHV infection

1 reference

12 December 2020

Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities

1 reference

12 December 2020

A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor.

1 reference

12 December 2020

Human biliary glycoproteins function as receptors for interspecies transfer of mouse hepatitis virus

1 reference

12 December 2020

Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I

1 reference

12 December 2020

Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2.

2 references

12 December 2020

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors

1 reference

12 December 2020

Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV

1 reference

12 December 2020

Episodic evolution mediates interspecies transfer of a murine coronavirus

1 reference

12 December 2020

Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion.

2 references

12 December 2020

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.005

7 January 2021

10.1016/J.VIROL.2004.04.005

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

15207636